During the past decade, Universitäts-Augenklinik Bonn conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitäts-Augenklinik Bonn" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "Johns Hopkins University" with 1 trials sponsored, "Kubota Vision Inc." with 1 trials sponsored and "Newtricious R&D BV" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäts-Augenklinik Bonn" #1 collaborator was "Sprim Advanced Life Sciences" with 1 trials as a collaborator and "The Shulsky Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitäts-Augenklinik Bonn" are "Geographic Atrophy" (6 trials), "Stargardt Disease" (2 trials), "Age-related Macular Degeneration (AMD)" (1 trials), "Diabetic Macular Edema" (1 trials) and "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Universitäts-Augenklinik Bonn" in a lesser frequency.

Most popular intervention types in "Universitäts-Augenklinik Bonn" are "Drug" (8 trials), "Other" (4 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "APL-2" (2 trials), "Lampalizumab" (2 trials), "Placebo" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitäts-Augenklinik Bonn" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Universitäts-Augenklinik Bonn". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitäts-Augenklinik Bonn, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitäts-Augenklinik Bonn, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".